Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

53 trials with published results (14%)

Research Maturity

269 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

24 terminated out of 383 trials

Success Rate

91.8%

+5.3% vs benchmark

Late-Stage Pipeline

25%

95 trials in Phase 3/4

Results Transparency

20%

53 of 269 completed with results

Key Signals

53 with results92% success24 terminated

Data Visualizations

Phase Distribution

332Total
Not Applicable (139)
Early P 1 (4)
P 1 (34)
P 2 (60)
P 3 (54)
P 4 (41)

Trial Status

Completed269
Unknown46
Terminated24
Recruiting14
Withdrawn9
Active Not Recruiting9

Trial Success Rate

91.8%

Benchmark: 86.5%

Based on 269 completed trials

Clinical Trials (383)

Showing 20 of 20 trials
NCT07569172Not ApplicableNot Yet Recruiting

Improved Child Nutrition and Development Through Social Transfers

NCT07545759Phase 2Not Yet Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

NCT05372068Not ApplicableActive Not Recruiting

Cement flooRs AnD chiLd hEalth (CRADLE)

NCT07230821Not ApplicableActive Not Recruiting

Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

NCT05814042Phase 2CompletedPrimary

Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea

NCT00093353Phase 1CompletedPrimary

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT06149715Not ApplicableCompleted

Water Filter Study in Ciudad Victoria

NCT07484412Not ApplicableActive Not Recruiting

Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms

NCT04038619Phase 1Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT07285785Phase 4RecruitingPrimary

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

NCT04486326Phase 4TerminatedPrimary

Crofelemer for Functional Diarrhea

NCT06333795Not ApplicableActive Not RecruitingPrimary

Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis

NCT07436104Phase 4Completed

Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.

NCT04826991Not ApplicableActive Not RecruitingPrimary

Wells and Enteric Disease Transmission

NCT07300462Phase 4Not Yet RecruitingPrimary

A Post-marketing Observational Study of Oral Cholera Vaccine

NCT07385196Recruiting

Defining Ileorectal Syndrome: a Prospective Observational Study

NCT05328037CompletedPrimary

Study on the Association Between Vitamin C Deficiency and Diarrhea in Children

NCT07338643Not Yet Recruiting

The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer

NCT07332078Not ApplicableCompletedPrimary

Meatsafe Food Storage and Diarrhea Prevention Trial in Urban Bangladesh

NCT07317167Not ApplicableEnrolling By Invitation

Evaluating a Water Safety Plan Intervention in Ghana

Scroll to load more

Research Network

Activity Timeline